7 Diagnostic and Genomic Stocks Storming Into October

COVID-19 has created an Apollo Mission status for advanced medical technologies and smart investors are profiting.

Articles You May Like

Brussels pushes for tougher sanctions enforcement via EU-wide body
Report: Huobi to Start Layoffs That Could ‘Exceed 30%’ — Founder May Sell Stake in Company
Report: Taiwan’s Central Bank May Need 2 Years to Complete Work on CBDC
Munis steady to firmer as NYC TFA prices
Investors see little to be gained in stocks the rest of the year, favor dividend payers now, CNBC survey shows